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Antibody molecules,  besides being  able  to  bind  relevant  antigenic  deter- 
minants,  can also function  as immunogens.  Antiantibodies  can  thus  be pro- 
duced against various parts of an antibody molecule. Antibodies directed at the 
antigen-binding sites or other unique parts of the variable area of the antibody 
molecule are called  anti-idiotype antibodies (1). Such anti-idiotype antibodies 
are regularly produced by F1 hybrid animals  injected with alloantibodies raised 
in one parental strain against the other parent (2, 3). Proof that it is the F1 hy- 
brid which elaborates such antialloantibodies  comes from an analysis of their 
allotype characteristics (4), the kinetics of their synthesis (5), and the fact that 
they are they are induced by determinants on the Fab portion of alloantibodies 
(6). 
Originally,  antialloantibodies were detected by their effect on recognition of 
alloantigens  by immunocompetent  cells,  which  was  specifically  inhibited  in 
certain in vitro systems (2), although not in others (7). Tests developed later in- 
eluded binding  of radiolabeled antialloantibody  (3)  and gel precipitation  (8). 
In vivo, the most striking effect was suppression of graft-vs.-host (GvH)  ~  reac- 
tivity of parental cells in Fx hybrids by passive transfer of antialloantiserum (9). 
This suggested that  the immunocompetent parental  T  lymphocyte, generally 
regarded as the principal actor in GvH, carried idiotypic determinants. It could 
indeed  be  shown  that  unfractionated  parental  lymphoid  cells  bound  radio- 
labeled  antialloantibody  (3). 
Using radiolabeled antialloantibodies, separation procedures to obtain "pure" 
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B and T lymphocytes, and allogeneic monolayers as specific immunoadsorbants, 
we found that antialloantibodies would only bind in significant quantities to B 
lymphocytes (10).  Furthermore, all idiotype-positive B lymphocytes had simi- 
lar antigen-binding specificity as evidenced by their adsorption to the relevant, 
allogeneic fibroblast monolayer. Preincubation with antialloantibody specifically 
blocked binding of B lymphocytes to monolayers. These results thus failed to 
demonstrate idiotypic receptors on T  lymphocytes as measured by the direct 
radioimmunoassay. However,  in  preliminary tests  the  antialloantibody-con- 
taining sera selectively inhibited binding of immunopotent T  cells to the rele- 
vant monolayers as tested by subsequent GvH reactions. In the present ex- 
periments we have analyzed the capacity of antialloantibody-containing sera to 
affect immunocompetent T  lymphocytes, and have established specific  inhibi- 
tory effects on purified T lymphocytes of relevant genotype. 
Materials and Methods 
Animals,  alloantisera,  antialloantisera, iodination, and  absorption of  antialloantibodies, 
rabbit antirat Ig and anti-T sera, normal lymphoid cell suspensions, reactions between iodi- 
nated antialloanfibodies and lymphoid cells, cytotoxic assays, column purifications of B and T 
cells,  rat fibroblast monolayers, and treatment of lymphoid cells with antisera were as de- 
scribed in the preceding paper (10). 
Incubation  of Lymphoid  Cells with Rat Fibroblast Monolayers.--lO 8 spleen cells pretreated 
in the manners described in the text, suspended in tissue culture medium (TCM)  199 supple- 
mented with 15% fetal calf serum (FCS) and antibiotics, were left in contact with rat fibro- 
blast monolayers for 180 min at 37°C,  shaking very gently after 90 min. After incubation cul- 
ture flasks were shaken gently for 15 min on a rocker. Cells in the supernate were harvested 
and the attached cells were eluted with Eagle's basal medium  (BME) containing 0.0025 M 
EDTA by shaking the flasks again on the rocker. Cells from the supernate and cells eluted with 
EDTA were then washed and trypsinized with 0.25% trypsin for 10 min at 37  °. Trypsiniza- 
tion was stopped by adding 10% FCS. Cells were washed twice with BME, filtered through 
nylon mesh, and incubated overnight in TCM 199 with 15% FCS and antibiotics. The next 
day, cells were washed twice with BME; they were then used for testing their ability to ab- 
sorb iodinated anfialloantibody and their GvH reactivity. 
Popliteal  Lymph Node Assay.--Usually  5 X  106 lymphoid cells in 0.1 ml were injected into 
the footpads of 5-8-wk old F1 animals. Rats were killed 7 days later and the lymph nodes 
were excised and weighed (9,  11). 
RESULTS 
Role of T Cells in the Local Popliteal Rat Lymph Node Assay.--The GvH po- 
tential of lymphocytes is thought to measure T-lymphocyte activity (12). Since 
it has been claimed (13) that B lymphocytes may participate in certain GvH re- 
actions we considered it essential to establish that our test system measured 
exclusively the immune reactivity of T lymphocytes. Comparatively pure T and 
B  lymphocyte populations  can  be  produced  from mixtures  by  several  pro- 
cedures. We used the capacity of anti-T or anti-Ig sera in the presence of com- 
plement to selectively lyse T and B lymphocytes, respectively. The lymphocytes 
thus obtained were then tested for their capacity to produce a local popliteal HANS  BINZ,  JEAN  LINDEN'MANN,  AND  HANS  WIGZELL  733 
lymph node reaction (Table I). Treatment with anti-T serum almost completely 
wiped out GvH reactivity whereas treatment with anti-Ig serum had no  such 
effect. We concluded that only T lymphocytes were important in this assay. 
Capacity of AntiaUoantibody-Containing Serum to Inhibit the Grit Reaction of 
Purified Parental T  Lymphocfles.--We had shown previously that antialloanti- 
serum produced in F1 hybrids by the injection of alloantibodies from one paren- 
tal strain against the other specifically suppressed the GvH reactivity of lym- 
phocytes from the former parental strain (9). The lymphocytes tested contained 
both T  and B  cells.  The results in Table I  suggest that inhibition involved T 
lymphocytes.  However,  the  possibility  remained  that  the  antialloantibodies 
TABLE  I 
T Lymphocytes as Effector Cells in the Local Popliteal Lymph Node Assay 
Mean lymph  Serum treatment  of injected  cells  node weights  Mean log ratio 4- SE 
Rabbit anti-T +  complement 
Complement alone 
Rabbit antirat Ig +  complement 
Complement alone 
mg 
26.7  --0.625  ±  0.166" 
107.8  " 
93.2  --0.024  ±  0.090:~ 
101.5  " 
Spleen cells from BN rats were treated as indicated and injected at doses of 5 X 10 6 cells 
into the footpads of (DA X BN)Ft rats. Antiserum-treated cells were injected into one foot- 
pad and control cells (treated with complement alone) into the other. Normal lymph nodes 
weighed between 5 and 10 mg. 
* Significantly different from 0. 
Not significantly different from 0. 
might primarily affect B lymphocytes; reaction with the idiotype-bearing cells 
might then create antigen-antibody complexes which inhibited the GvH reac- 
tion. Therefore, we tested highly purified T  lymphocytes from both parental 
strains  for  their  ability  to  provoke a  GvH reaction  in  animals  actively im- 
munized with alloantisera  (Table II). Even with "pure" T  lymphocytes there 
was a  selective, significant inhibition  of the  GvH reaction.  From the data in 
Tables I  and II we concluded that the inhibitory activity of antialloantibody 
serum as measured in the local popliteal lymph node assay was due to a direct 
inhibition of T  lymphocytes. 
Capacity of Antialloantibody-Containing Sera to Block the Binding of Specific 
T Lymphocytes to the Relevant Monolayers.--Little doubt exists that immune T 
lymphocytes involved in cell-mediated killing can be removed specifically by 
adsorption onto target monolayers. However, with normal T  lymphocytes the 
situation is less clear. It has been reported that normal T  lymphocytes poten- 
tially reactive in GvH or as killer cells can be removed by incubation on appro- 
priate monolayers  (14-16).  Others have failed  to remove normal  T  lympho- 
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TABLE  II 
GvH Induced  by Purified  Parental T Lymphocytes. Inhibition  by Immunization of (Lewis  X 
DA) Fx Hosts with Parental Alloantibodies 
Hosts  immunized with DA anti-Lewis* 
DA node~  Lewis node~  Ratio 
mg  mg 
16.0  53.5  0.30 
38.0  102.7  0.37 
44.5  111.5  0.40 
56.8  116.1  0.49 
34.6  65.5  0.53 
43.7  83.0  0.53 
41.4  70.2  0.59 
48.5  75.8  0.64 
56.7  80.6  0.70 
37.5  51.2  0.73 
39.8  51.8  0.77 
45.0  38.5  1.17 
Mean log ratio 4- SE =  --0.240 4- 0.044§ 
Hosts  immunized with Lewis Anti-DA* 
DA node~  Lewis node~  Ratio 
mg  rag 
92.5  62.4  1.48 
99.0  60.0  1.65 
97.3  57.7  1.69 
126.8  68.0  1.86 
133.4  64.9  2.06 
49.0  23.4  2.09 
98.2  43.9  2.24 
88.7  38.4  2.31 
127.0  51.3  2.48 
71.2  23.4  3.04 
Mean log ratio 4- SE =  0.314  4- 0.028§ 
* FI hosts were immunized by two subcutaneous injections of 1 ml of alloantiserum at 10- 
day intervals. GvH reactions were induced two days after the second injection by purified 
parental T  lymphocytes. DA cells were injected into one footpad  and  Lewis cells into  the 
other. 
~t Popliteal lymph node weights (mg), in individual rats. "Lewis node" refers to the node 
from the side on which Lewis T  cells were injected, "DA node" to the side of the DA T cell. 
§ Both values differ significantly from 0. 
results, we have found it possible to remove rat GvH-reactive cells by preincu- 
bation on the relevant monolayer.  Table III  shows a  comparative  assay when 
normal  parental  lymphocytes  (both  B  and  T  lymphocytes)  were allowed first 
to react with syngeneic or allogeneic fibroblast monolayers. The incubation was HANS BINZ~ JEAN LINDENMANN,  AND HANS WIGZELL  735 
TABLE  III 
Interference  with the Adsorption of GvH-Reactive  Cells and [*251]Antialloantibody-Reactive  Cells 
onto Allogeneic Fibroblast Monolayers. Effect of A nti-Ig and A ntialloantibody  Sera 
Cells remaining in the supernatant after 
adsorption onto: 
ScPe•s  n  Treatment  with sera  DA monolayer  Lewis  monolayer  Mean log ratio :h SE* 
GvH  Binding of  Binding of 
activity  [125I]anti'(L  GvH  [12sI]  anti- 
anti-DA)  activity (DA anti-L) 
DA 
Lewis 
mg  ¢pm  mg  cpm 
F1 anfi-(DA anti-L)  75.2  ND  86.3  316  0.063  4-  0.060 
F1 normal serum  88.8  ND  58.4  127  --0.188  ±  0.025 
Rabbit antirat Ig  94.2  ND  62.8  369§  --0.178  4-  0.029 
F1 anti-(L anti-DA)  85.6  486  72.1  ND  0.069  4- 0.047 
F, normal serum  77.6  110  99.3  ND  0.115  4- 0.164 
Rabbit antirat Ig  66.7  630§  107.5  ND  0.198  4-  0.045 
* Ratio of lymph node weights induced by cells after absorption  with Lewis (L) mono- 
layers over lymph node weights induced by cells after absorption with DA monolayers. Small- 
est significant value  (P <  0.05) is 0.110. Values not significantly different from zero (bold- 
faced) indicate  that allogeneic monolayer was not more effective in removing GvH-reactive 
cells than syngeneic monolayer. 
:~ Mean weight of three lymph nodes (rag). Boldfaced values indicate reduced absorption 
by relevant monolayer. 
§ Mean uptake of radioactivity by 5 X  l0 s cells (cpm). Boldfaced values indicate reduced 
absorption by relevant monolayer. 
carried out in the presence of anti-Ig serum, normal F1 serum or antialloanti- 
body-containing serum of relevant specificity. The capacity of the reagents  to 
interfere with B-cell binding was analyzed by radioimmunoassay  (3) and with 
T-cell binding by the GvH test. Both anti-Ig and antialloantibody serum spe- 
cifically inhibited the binding of B cells to the relevant monolayer, whereas only 
the antialloantibody serum would block the binding of T  lymphocytes (under- 
lined  figures  in  Table  III).  Thus,  anti-(DA  anti-Lewis)  serum  inhibited  the 
attachment of DA cells onto Lewis monolayers, as evidenced by greater GvH re- 
activity of the cells remaining in the supernate and by the fact that such serum- 
treated cells were no longer preferentially absorbed by the allogeneic monolayer 
as compared to the syngeneic monolayer (Table  III, line  1).  In contrast,  DA 
cells treated with normal F1 serum were depleted from the supernate after con- 
tact with the Lewis monolayer, whereas the syngeneic monolayer had no such 
effect  (Table  III, line  2).  Absorption of GvH-reactive  cells  by the  allogeneic 
monolayer was not impaired by pretreatment  with antiserum  to rat Ig (Table 
III, line 3). However, both antialloantibody and anti-Ig inhibited  the absorp- 
tion, by the allogeneic monolayer, of those cells which were capable of binding 
significant amounts of iodinated antialloantibody,  confirming the B-cell nature 736  CELL  RECEPTORS  FOR  ALLOANTIGENS.  II 
of these cells  (Table III, lines  1 and 3).  Corresponding results  were obtained 
with Lewis cells as aggressors (Table III, lines 4-6). 
In a further series of tests we analyzed the effects of anti-Ig, anti-T, normal 
F1 or antialloantibody sera on  the  capacity of GvH-reactive cells  to bind  to 
syngeneic or allogeneic monolayers. We have already shown that B-cell binding 
to monolayers is inhibited by anti-Ig and antialloantiboy sera  (10 and Table 
III). When GvH-reactive cells were incubated on syngeneic monolayers (Table 
IV) the presence of various antisera did not affect the distribution of reactive 
TABLE IV 
Binding  and  Elution  of GvH-Reactive Cells to  Cellular Monolayers.  Interference  by A nti-Ig 
A nil-T, and A ntialloantibody Sera 
GvH reactivity of: 
Spleen  Serum treatment of spleen cells  Mono-  Mean log ratio  cells  layers  Cells in  Eluted  4- SE:~ 




mg  rag 
Rabbit antirat Ig  DA  27.3  42.5  --0.192  4-  0.019 
Rabbit anti-T  "  47.9  61.2  -0.111  4-  0.043 
(DA X  L)Ft normal  "  25.4  37.8  --0.185  4-  0.077 
(DA X  L)FI anti-(L anti-DA)  "  30.3  15.3  0.297 4- 0.018 
Rabbit antirat Ig  Lewis  39.3  36.3  0.035  4-  0. 010 
Rabbit anti-T  "  48.3  53.5  0.033  4-  0.014 
(DA X  L)F1 normal  "  24.6  24.5  0.000  4-  0.046 
(DA X  L)Ft anti-(L anti-DA)  "  37.5  37.1  0.007  4-  0.030 
Rabbit antirat Ig  DA  46.9  46.7  --0.006  4-  0.039 
Rabbit anti-T  "  50.5  52.1  --0.020  4-  0.060 
(DA X  L)Ft normal  "  36.0  36.1  0.008  4-  0.032 
(DA X  L)F1 anti-(DA anti-L)  "  34.9  35.1  --0.056 4-  0.016 
Rabbit antirat Ig  Lewis  32.9  46.2  --0.151  4-  0.024 
Rabbit anti-T  "  49.1  67.8  --0.148  4-  0. 044 
(DA X  L)F1 normal  20.6  41.3  --0.304  4-  0.018 
(DA X  L)Fl anti-(DA anti-L)  "  42.3  15.9  0.US 4-  0.060 
* Mean weight of three lymph nodes  (nag). 
Ratio of node weight induced by cells in supcrnate over node weight induced by cells in eluate. Boldfaced 
values denote blocking of specific adsorption. 
cells in the supernates. However, in all six experiments in which anti-Ig, anti-T, 
or normal F2 serum was added with the GvH-reactive cells to allogeneic mono- 
layers,  there  was a  significant  shift in  the ratio.  More specific GvH-reactive 
cells were now found in the bound and eluted (with EDTA) cell fractions. Thus, 
again we could show that GvH-reactive cells bound to allogeneic monolayers. 
Antialloantibody-containing serum specifically blocked the binding of GvH-re- 
active cells to allogeneic monolayers (see boldfaced combinations) as evidenced 
by a  change in  the ratios of GvH-reactive cells in supernate  vs.  eluate.  The 
reason why the cells in the eluate had such poor overall GvH reactivity is un- 
clear but this was found repeatedly. 
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could be removed by preincubation in vitro with the appropriate monolayers 
and  (b)  of the sera tested, those containing antialloantibody could block the 
binding of both  GvH-reactive cells  and B  lymphocytes, whereas  (c)  anti-lg 
serum would only block the binding of B lymphocytes. 
Cytotoxic  Effects of Antialloantibody Serum on Grit-Reactive Cells.--We have 
found previously that antialloantibody sera in the presence of complement were 
cytotoxic for the relevant, idiotype-positive B lymphocytes (10). We now tested 
whether antialloantibody-containing serum in the presence of complement was 
similarly cytotoxic for GvH-reactive lymphocytes. Cells to be tested were incu- 
bated with antialloantiserum in the presence or absence of complement or with 
complement alone. They were then washed, trypsinized, allowed to recover, and 
tested for their capacity to induce GvH reactions in the local popliteal lymph 
node assay. As controls, anti-Ig or anti-T sera were tested for cytotoxic activity 
in the same assay. Anti-T or antialloantibody-containing sera inhibited GvH 
activity in this assay (Table V) whereas, as expected from the previous findings, 
anti-Ig and complement did not reduce the GvH potential. Table VI shows that 
antialloantibody-containing serum without complement was ineffective in this 
TABLE  V 
C~H Reactivity of Parental Lymphoid Cells Treated with Different Antisera plus  Complement, in 
Comparison to the Reactivity of the Same Cells Treated with  Complement Alone 
Mean 
Cells  lymph  Mean log ratio  injected  Host  Injected cells treated with  noae  -4- SE 
weights* 
mg 
Lewis  (L X  BN)F1  Ft anti-(L anti-BN) -{- complement  22.7  --0.444  ~  0.062~ 
Complement alone  62.1  " 
Rabbit anti-T -{- complement  12.7  --0.499  -4- 0.062~ 
Complement alone  39.6  " 
Rabbit antl-rat Ig +  complement  53.8  --0.003  ~  0.199 
Complement alone  56.1  " 
BN  (L X  BN)F1  F1 anti-(BN anti-L) -{- complement  51.9  -0.254 -4- 0.125~ 
Complement alone  95.2  " 
Rabbit anti-T -{- complement  52.9  --0.180  +  0.044~t 
Complement alone  81.0  " 
Rabbit  anti-rat Ig +  complement  91.3  0.083 4- 0.053 
Complement alone  76.2  " 
DA  (DA X  BN)F1  Fi anti-(DA anti-BN) +  complement  27.5  -0.631  -4- 0.1801: 
Complement alone  97.1  " 
Rabbit anti-T +  complement  40.4  --0.467  -4- 0.190:]: 
Complement alone  107.3  " 
Rabbit anti-rat Ig +  complement  81.2  O. 037  -4- O. 065 
Complement alone  75.2  " 
BN  (DA X  BN)F1  F1 anti-(BN anti-DA) -~- complement  42.2  --0.404  +  0.176:~ 
Complement alone  112.0  " 
*  Mean weight of three nodes (rag). 
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TABLE VI 
GvH Reaction of Parental Lymphoid Cells Treated  with Antialloantibodies plus Complement  in 
Comparison to the GvH Reaction of Parental Lymphoid Cells Treated with A ntialloantibodies 
Alone or Complement Alone 
Cells  Mean lymph  Mean  log ratio 
injected  Host  Injected cells treated with  node weights  -4- SE*  -4- SE 
DA  (DA X  BN)Ft 
Lewis  (L X  BN)Fj 
mg 
Anti-(DA anti-BN)  +  complement  17.7  4-  1.0  --0.327  4-  0.0385 
Anti-(DA anti-BN)  37.8  4-  2.4  " 
Anti:(DA anti-BN)  +  complement  18.3  4-  1.1  --0.209  -4-  0.031~ 
Complement alone  30.5  4-  3.2  " 
Anti-(L anti-BN)  +  complement  15.7  :t: 0.8  --0.208  -4-  0.027:~ 
Anti-(L anti-BN)  25.3  -4-  1.2  " 
Anti-(L anti-BN)  +  complement  13.6  4-  0.9  --0.238  -4-  0.024~ 
Complement alone  23.5  4-  1.0  " 
* Mean of between  16 and 22 lymph nodes. 
~/Significantly different from zero. 
assay. This suggested that the inhibition of GvH reactivity was due to killing 
of the reactive cells rather than to blocking. Cytotoxicity was not apparent by 
trypan blue uptake, probably because antiserum-sensitive cells were infrequent. 
Not  all  antialloantibody-containing sera  proved  cytotoxic for  GvH-reactive 
cells. Of the eight sera positive by other tests only four appeared to be cytotoxic. 
We would thus conclude that several of our antialloantibody-containing sera 
behaved as though they contained antibodies cytotoxic for the relevant GvH- 
reactive T  lymphocytes. 
DISCUSSION 
Our present data support the view that antisera produced in F1 hybrids to the 
alloantibodies of one parental strain against the other contain antibodies reac- 
tive with antigen-binding receptors on T lymphocytes. Such receptors would be 
present  on T  lymphocytes from the  strain  that  produced the  alloantibodies 
used  for inoculation into  the  F1 hybrid animals,  and would  carry specificity 
for the alloantigens of the other parental strain.  The evidence for this comes 
from the findings that "pure" T lymphocytes were selectively inhibited in their 
GvH reactivity when inoculated into F1 hybrids actively immunized with allo- 
antibodies.  Furthermore,  binding  of  GvH-reactive cells  (we  found  as  have 
others that these cells  were T  lymphocytes) to the relevant allogeneic mono- 
layers was inhibited by antialloantibody-containing sera. And finally, in several 
experiments we could demonstrate that T  lymphocytes incubated with anti- 
alloantibody and complement no longer induced GvH reactions. Our data thus 
confirm and extend previous reports of the specific inhibitory activity of anti- 
alloantibody serum on GvH reactivity (8, 9), and demonstrate that the effect 
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There  are,  however, several seemingly  contradictory findings  in  this  field. 
Antialloantibody IgG radiolabeled with l~I bound significantly  to the appropri- 
ate parental lymphocytes, but apparently only to B lymphocytes (10). Yet, the 
same serum (pure IgG has not been tested) inhibited the binding of T lympho- 
cytes to the relevant allogeneic monolayers and inhibited the GvH reactivity of 
inoculated T  lymphocytes in vivo (present  article and 9).  There  are several 
possible explanations.  The T  cells might  not have receptors with  the B-cell 
idiotype against which the antialloantibodies are directed. Alternatively, the T 
lymphocytes might have the same receptors as B lymphocytes but fail to express 
them in a way allowing detection by binding assays. A further possibility is that 
the specific factor in the antialloantibody-containing  sera that  reacts with T 
lymphocytes is not an antialloantibody after all. It might be a complex consist- 
ing of alloantibody and antigen of the other parental strain, produced in the F1 
hybrid as a consequence of the injection of alloantibody. The strongest argu- 
ment against this latter possibility would seem to be the demonstration (Tables 
V and VI) that four of the antialloantibody-containing sera appeared to be cyto- 
toxic for the appropriate T  lymphocytes in the presence of complement. It is 
theoretically conceivable, although  unlikely,  that antigen-antibody complexes 
in antigen excess might bind to the relevant antigen-binding T  Cells, then fix 
complement via antibody and kill T lymphocytes indirectly. 
However, it is possible that the alloantiserum injected into the F1 hybrids to 
induce antialloantibodies might contain, besides "classical" alloantibody, some 
soluble antigen-specific  lymphocyte product leading to the elaboration of anti- 
receptor antibodies (Ramseier and Lindenmann, to be published). Antireceptor 
antibodies raised against parental spleen cells have been shown to inhibit lethal 
GvH (18). When "pure" T-lymphocyte suspensions were used as the immuniz- 
ing agent,  inhibition  of local  GvH could also  be demonstrated  (Wigzell  and 
Binz,  in  preparation).  In  addition,  "pure"  T  cells  proved  reactive  against 
foreign alloantigens in the PAR assay (19) and were able to induce formation of 
antireceptor antibodies (20). It appears even possible to raise xenogeneic  sera 
against  T-cell  receptors by immunization  of rabbits  with  killer  mouse  cells 
sensitized  across an 1:1-2 barrier; after proper absorption this serum inhibited 
only the relevant killer cells (21). 
In conclusion,  the present article shows that sera from F1 hybrids inoculated 
with posttransplantation alloantibodies produced in one parental strain against 
the other contain specific factors capable of reacting with B and T lymphocytes 
of the alloantibody donor genotype. It is unknown whether the same specific 
factor reacts with both B  and T  lymphocytes from the same individual.  The 
factor reactive with B lymphocytes is known to be antibody, some of which is 
IgG (10). We have no evidence about the chemical  nature of the anti-T factor. 
Since it is specific and sometimes cytotoxic for the relevant T lymphocytes it 
may well be antibody to the idiotype of T receptors. Whatever the exact mecha- 
nism  for the observed specific T-cell  suppression,  it  holds promises both for 
theoretical insights  and practical applications. 74O  CELL RECEPTORS FOR ALLOANTIGENS. II 
SUMMARY 
The rat popliteal node graft-vs.-host assay was shown to depend on the pres- 
ence of parental  T  cells in the  inoculum.  Antialloantisera  raised  in F1 hybrid 
rats  against  alloantibodies  of one parent  directed  at  transplantation  antigens 
of the  other  parent  displayed  some or  all  of the  following specific effects on 
parental T  cells: They inhibited local GvH by purified T-cell suspensions; they 
blocked  the  capacity  of  GvH-reactive  cells  to  adsorb  onto  fibroblast  mono- 
layers of the relevant genotype; together with  complement,  they killed  GvH- 
reactive cells. 
We thank Prof. H. Ramseier for discussions and Miss R. Leemann for help. 
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